poster

Esmolol Population Pharmacokinetics in Critically-ill, Pediatric Patients

Thursday 16 October, 2025

PDF of poster Introduction: Esmolol has recently been studied in two clinical trials from which population pharmacokinetics have been derived:…

Read more

Establishing a tool for individualised dosing of gabapentin – The use of a non-parametric population kinetics model in the MM-USCPACK software, a new tool for clinical dosage optimization.

Thursday 16 October, 2025

To be able to use pharmacokinetic tools in clinical practice, they must be easily available to the physician at the…

Read more

A non-parametric (NPAG) population PK model of orally and intravenously administered linezolid.

Thursday 16 October, 2025

Objectives: Population PK of linezolid (LNZ) has been characterized in several relatively recent publications, but with divergent conclusions regarding linear…

Read more

A Markov Model For The Effect Of Covariates Including Drug Adherence On Longitudinal Viral Response In HIV Patients

Thursday 16 October, 2025

Objectives: We investigate the effect of adherence to prescribed antiviral drugs on viral response in PI treatment failures randomized to…

Read more

Characterization of Cortisol Circadian Rhythm and Lack of Cortisol Suppression by a New Corticosteroid, Ciclesonide

Thursday 16 October, 2025

PDF of poster Objective: Ciclesonide (CIC) is a new inhaled glucocorticoid for the treatment of asthma that is converted into…

Read more

Simultaneous vs. Sequential Estimation in PK/PD Data Analysis

Thursday 16 October, 2025

Introduction Rational drug dosing requires knowledge of the dose[– concentration] – effect relationship, which can be obtained by estimating a…

Read more

Population pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination

Thursday 16 October, 2025

Objective: Characterization of the pharmacodynamic interaction between the antiepileptic drugs tiagabine and lamotrigine on basis of the anticonvulsant effect in…

Read more

Development and validation of a mechanism-based PK/PD model for the in vitro-in vivo prediction of QT prolongation by dofetilide

Thursday 16 October, 2025

PDF of poster Objectives: Drug-induced QT prolongation is an important biomarker for assessing the risk of heart arrhythmias and reflects…

Read more

Discussion of criteria for evaluating the quality of glucose clamp studies

Thursday 16 October, 2025

The pharmacodynamic (PD) action of insulin and insulin analogues is the lowering of the blood glucose concentration (BG) by increased…

Read more

Markedly different predictions about insulin PharmacoDynamic (PD) measurement feasibility in healthy subjects from recently proposed IntraVenousGlucoseToleranceTest (IVGTT)-based insulin-glucose models

Thursday 16 October, 2025

Objectives: Evaluating the correspondence between insulin PD measurements by glucose clamps and IVGTT-based insulin-glucose models. Methods: We compared two recent…

Read more